Evidence map›Paper›PMID 42750045›Full record

ArticleJournal of translational medicine2026

Correction to: The plasma nanoDSF denaturation profiles predict the presence of breast cancer.

Mathilde Guerin, Rémi Eyraud, Philipp O Tsvetkov, Pascal Finetti, Alexandre Giraudo, Carole Tarpin, Aymen Hassin, Didier Bechlian, Emilie Mamessier, Jihane Pakradouni and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Mathilde Guerin *Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Rémi Eyraud *Université Jean Monnet Saint-Etienne, CNRS, Institut d'Optique Graduate School, Laboratoire Hubert Curien, UMR 5516, Saint-Etienne, France.
Philipp O Tsvetkov *Aix Marseille Univ, CNRS INP, Inst Neurophysiopathol, Marseille, France.
Pascal FinettiPredictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Label " Ligue Contre le Cancer ", 232, bd de Sainte-Marguerite, Marseille, 13009, France.
Alexandre GiraudoDepartment of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Carole TarpinDepartment of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Aymen HassinAix Marseille Univ, CNRS INP, Inst Neurophysiopathol, Marseille, France.
Didier BechlianBiobank, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Emilie MamessierPredictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Label " Ligue Contre le Cancer ", 232, bd de Sainte-Marguerite, Marseille, 13009, France.
Jihane PakradouniDepartment of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
Jean-Marie BoherDepartment of Biostatistics, Institut Paoli-Calmettes, Marseille, France.
Anthony GoncalvesDepartment of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
François Devred *Aix Marseille Univ, CNRS INP, Inst Neurophysiopathol, Marseille, France.
François Bertucci *Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France. bertuccif@ipc.unicancer.fr.ORCID http://orcid.org/0000-0002-0157-0959

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42750045
PMCPMC13579881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.